| Database of p53 gene somatic mutations in human tumors and cell lines. M Hollstein, K Rice, MS Greenblatt, T Soussi, R Fuchs, T Sřrlie, E Hovig, ... Nucleic acids research 22 (17), 3551, 1994 | 1358 | 1994 |
| Assessing TP53 status in human tumours to evaluate clinical outcome T Soussi, C Béroud Nature Reviews Cancer 1 (3), 233-239, 2001 | 912 | 2001 |
| Structural aspects of the p53 protein in relation to gene evaluation T Soussi Oncogene 5, 945-952, 1990 | 861 | 1990 |
| p53 Antibodies in the sera of patients with various types of cancer: a review T Soussi Cancer research 60 (7), 1777-1788, 2000 | 803 | 2000 |
| TP53 tumor suppressor gene: a model for investigating human mutagenesis CCD Fromentel, T Soussi Genes, chromosomes and cancer 4 (1), 1-15, 1992 | 758 | 1992 |
| Somatic Point Mutations in the p53 Gene of Human Tumors and Cell Lines: Updated Compilation M Hollstein, B Shomer, M Greenblatt, T Soussi, E Hovig, R Montesano, ... Nucleic acids research 24 (1), 141-146, 1996 | 694 | 1996 |
| Multifactorial analysis of p53 alteration in human cancer: A review T Soussi, Y Legros, R Lubin, K Ory, B Schlichtholz International journal of cancer 57 (1), 1-9, 1994 | 517 | 1994 |
| The TP53 Colorectal Cancer International Collaborative Study on the Prognostic and Predictive Significance of p53 Mutation: Influence of Tumor Site, Type of … A Russo, V Bazan, B Iacopetta, D Kerr, T Soussi, N Gebbia Journal of clinical oncology 23 (30), 7518-7528, 2005 | 516 | 2005 |
| Integrated analysis of TP53 gene and pathway alterations in the cancer genome atlas LA Donehower, T Soussi, A Korkut, Y Liu, A Schultz, M Cardenas, X Li, ... Cell reports 28 (5), 1370-1384. e5, 2019 | 505 | 2019 |
| Shaping genetic alterations in human cancer: the p53 mutation paradigm T Soussi, KG Wiman Cancer cell 12 (4), 303-312, 2007 | 462 | 2007 |
| The p53 tumor suppressor gene: from molecular biology to clinical investigation T Soussi Annals of the new York Academy of Sciences 910 (1), 121-139, 2000 | 447 | 2000 |
| Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses B Royer, D Cazals-Hatem, J Sibilia, F Agbalika, JM Cayuela, T Soussi, ... Blood, The Journal of the American Society of Hematology 90 (2), 766-775, 1997 | 417 | 1997 |
| p53 mutation heterogeneity in cancer T Soussi, G Lozano Biochemical and biophysical research communications 331 (3), 834-842, 2005 | 407 | 2005 |
| APC gene: database of germline and somatic mutations in human tumors and cell lines C Béroud, T Soussi Nucleic acids research 24 (1), 121-124, 1996 | 400 | 1996 |
| Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects P Hainaut, T Soussi, B Shomer, M Hollstein, M Greenblatt, E Hovig, ... Nucleic acids research 25 (1), 151-157, 1997 | 399 | 1997 |
| TP 53 mutations in human cancer: database reassessment and prospects for the next decade B Leroy, M Anderson, T Soussi Human mutation 35 (6), 672-688, 2014 | 395 | 2014 |
| p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis T Soussi, K Dehouche, C Béroud Human mutation 15 (1), 105-113, 2000 | 383 | 2000 |
| Serum p53 antibodies as early markers of lung cancer R Lubin, G Zalcman, L Bouchet, J Trédaniel, Y Legros, D Cazals, A Hirsch, ... Nature medicine 1 (7), 701-702, 1995 | 370 | 1995 |
| The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot B Schlichtholz, Y Legros, D Gillet, C Gaillard, M Marty, D Lane, F Calvo, ... Cancer Research 52 (22), 6380-6384, 1992 | 357 | 1992 |
| TP53: an oncogene in disguise T Soussi, KG Wiman Cell Death & Differentiation 22 (8), 1239-1249, 2015 | 345 | 2015 |
